435 related articles for article (PubMed ID: 31865633)
1. Human regular U-500 insulin via continuous subcutaneous insulin infusion versus multiple daily injections in adults with type 2 diabetes: The VIVID study.
Grunberger G; Bhargava A; Ly T; Zisser H; Ilag LL; Malone J; Fan L; Zhang S; Johnson J
Diabetes Obes Metab; 2020 Mar; 22(3):434-441. PubMed ID: 31865633
[TBL] [Abstract][Full Text] [Related]
2. The Effect of Prestudy Insulin Therapy on Safety and Efficacy of Human Regular U-500 Insulin by Pump or Injection: A Posthoc Analysis.
Hood RC; Chen Y; Sindelar DK; Ly T; Juneja R; Pollom RD; Ilag L; Wysham C
Endocr Pract; 2021 Aug; 27(8):783-789. PubMed ID: 33515757
[TBL] [Abstract][Full Text] [Related]
3. Glucose Variability and Time in Range in Type 2 Diabetes Treated with U-500R by Pump or Injection: CGM Findings from the VIVID Study.
Blevins T; Lane W; Rodbard D; Sindelar D; Fan L; Ellinor K; Ilag L; Ly T; Johnson J
Diabetes Technol Ther; 2021 Jan; 23(1):51-58. PubMed ID: 32631081
[No Abstract] [Full Text] [Related]
4. Continuous subcutaneous insulin infusion versus multiple daily injections in children and young people at diagnosis of type 1 diabetes: the SCIPI RCT.
Blair J; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes D; Gamble C
Health Technol Assess; 2018 Aug; 22(42):1-112. PubMed ID: 30109847
[TBL] [Abstract][Full Text] [Related]
5. Effect of initiating use of an insulin pump in adults with type 1 diabetes using multiple daily insulin injections and continuous glucose monitoring (DIAMOND): a multicentre, randomised controlled trial.
Beck RW; Riddlesworth TD; Ruedy KJ; Kollman C; Ahmann AJ; Bergenstal RM; Bhargava A; Bode BW; Haller S; Kruger DF; McGill JB; Polonsky W; Price D; Toschi E;
Lancet Diabetes Endocrinol; 2017 Sep; 5(9):700-708. PubMed ID: 28711468
[TBL] [Abstract][Full Text] [Related]
6. Patient-reported outcomes in a study of human regular U-500 insulin delivered by continuous subcutaneous insulin infusion or multiple daily injections in patients with type 2 diabetes.
Chen J; Fan L; Peng X; Ilag L; Ly T; Johnson J
Diabetes Obes Metab; 2021 Jan; 23(1):240-244. PubMed ID: 32893428
[TBL] [Abstract][Full Text] [Related]
7. Continuous subcutaneous insulin infusion versus multiple daily injection regimens in children and young people at diagnosis of type 1 diabetes: pragmatic randomised controlled trial and economic evaluation.
Blair JC; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes DA; Gamble C;
BMJ; 2019 Apr; 365():l1226. PubMed ID: 30944112
[TBL] [Abstract][Full Text] [Related]
8. Comparison between a multiple daily insulin injection regimen (basal once-daily glargine plus mealtime lispro) and continuous subcutaneous insulin infusion (lispro) using continuous glucose monitoring in metabolically optimized type 1 diabetes patients: A randomized open-labelled parallel study.
Ruiz-de-Adana MS; Dominguez-Lopez ME; Gonzalez-Molero I; Machado A; Martin V; Cardona I; de-la-Higuera M; Tapia MJ; Soriguer F; Anarte MT; Rojo-Martínez G
Med Clin (Barc); 2016 Mar; 146(6):239-46. PubMed ID: 26656958
[TBL] [Abstract][Full Text] [Related]
9. HbA1c variability in adults with type 1 diabetes on continuous subcutaneous insulin infusion (CSII) therapy compared to multiple daily injection (MDI) treatment.
Scott ES; McGrath RT; Januszewski AS; Calandro D; Hardikar AA; O'Neal DN; Fulcher G; Jenkins AJ
BMJ Open; 2019 Dec; 9(12):e033059. PubMed ID: 31888933
[TBL] [Abstract][Full Text] [Related]
10. The Impact of Insulin Pump Therapy on Glycemic Profiles in Patients with Type 2 Diabetes: Data from the OpT2mise Study.
Conget I; Castaneda J; Petrovski G; Guerci B; Racault AS; Reznik Y; Cohen O; Runzis S; de Portu S; Aronson R;
Diabetes Technol Ther; 2016 Jan; 18(1):22-8. PubMed ID: 26241790
[TBL] [Abstract][Full Text] [Related]
11. Continuous subcutaneous insulin infusion vs modern multiple injection regimens in type 1 diabetes: an updated meta-analysis of randomized clinical trials.
Pala L; Dicembrini I; Mannucci E
Acta Diabetol; 2019 Sep; 56(9):973-980. PubMed ID: 30945047
[TBL] [Abstract][Full Text] [Related]
12. Continuous subcutaneous insulin infusion therapy is associated with reduced retinopathy progression compared with multiple daily injections of insulin.
Reid LJ; Gibb FW; Colhoun H; Wild SH; Strachan MWJ; Madill K; Dhillon B; Forbes S
Diabetologia; 2021 Aug; 64(8):1725-1736. PubMed ID: 33966091
[TBL] [Abstract][Full Text] [Related]
13. Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens using insulin lispro in type 1 diabetic patients on intensified treatment: a randomized study. The Study Group for the Development of Pump Therapy in Diabetes.
Hanaire-Broutin H; Melki V; Bessières-Lacombe S; Tauber JP
Diabetes Care; 2000 Sep; 23(9):1232-5. PubMed ID: 10977011
[TBL] [Abstract][Full Text] [Related]
14. Clinical use of U-500 regular insulin: review and meta-analysis.
Reutrakul S; Wroblewski K; Brown RL
J Diabetes Sci Technol; 2012 Mar; 6(2):412-20. PubMed ID: 22538155
[TBL] [Abstract][Full Text] [Related]
15. Optimizing type 1 diabetes after multiple daily injections and capillary blood monitoring: Pump or sensor first? A meta-analysis using pooled differences in outcome measures.
Thomas MG; Avari P; Godsland IF; Lett AM; Reddy M; Oliver N
Diabetes Obes Metab; 2021 Nov; 23(11):2521-2528. PubMed ID: 34286892
[TBL] [Abstract][Full Text] [Related]
16. Glycemic Outcomes in Adults With T1D Are Impacted More by Continuous Glucose Monitoring Than by Insulin Delivery Method: 3 Years of Follow-Up From the COMISAIR Study.
Šoupal J; Petruželková L; Grunberger G; Hásková A; Flekač M; Matoulek M; Mikeš O; Pelcl T; Škrha J; Horová E; Škrha J; Parkin CG; Svačina Š; Prázný M
Diabetes Care; 2020 Jan; 43(1):37-43. PubMed ID: 31530663
[TBL] [Abstract][Full Text] [Related]
17. Combined continuous glucose monitoring and subcutaneous insulin infusion versus self-monitoring of blood glucose with optimized multiple injections in people with type 1 diabetes: A randomized crossover trial.
Dicembrini I; Pala L; Caliri M; Minardi S; Cosentino C; Monami M; Mannucci E
Diabetes Obes Metab; 2020 Aug; 22(8):1286-1291. PubMed ID: 32166907
[TBL] [Abstract][Full Text] [Related]
18. Intensive insulin therapy combined with metformin is associated with reduction in both glucose variability and nocturnal hypoglycaemia in patients with type 2 diabetes.
Zhang Y; Zhao Z; Wang S; Zhu W; Jiang Y; Sun S; Chen C; Wang K; Mu L; Cao J; Zhou Y; Gu W; Hong J; Wang W; Ning G
Diabetes Metab Res Rev; 2017 Oct; 33(7):. PubMed ID: 28609547
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and Pharmacodynamics of Human Regular U-500 Insulin Administered via Continuous Subcutaneous Insulin Infusion Versus Subcutaneous Injection in Adults With Type 2 Diabetes and High-Dose Insulin Requirements.
Ma X; Benson CT; Prescilla R; Zhang S; Linnebjerg H; LaBell ES; Morrow LA; Jackson JA; Nguyen A; Ilag LL; Johnson JL; Leishman D
J Diabetes Sci Technol; 2022 Mar; 16(2):401-407. PubMed ID: 33242998
[TBL] [Abstract][Full Text] [Related]
20. Glyco-metabolic control, inflammation markers, and cardiovascular outcomes in type 1 and type 2 diabetic patients on insulin pump or multiple daily injection (italico study).
Derosa G; Catena G; Scelsi L; D'Angelo A; Raddino R; Cosentino E; Maggi A; Pasini G; Borghi C; Maffioli P
Diabetes Metab Res Rev; 2020 Jan; 36(1):e3219. PubMed ID: 31642581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
